Derivative exercise or conversion — not an open-market buy.
Loading…
Traded May 15, 2026 · Filed May 18, 2026
The money chief of Encompass Health sold $2.96M of Encompass Health shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,958,443
Shares × reported transaction price
15 days after results of Apr 30, 2026, 82 days before results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.1% | +2.3% | −2.2% |
| 30 days | −6.4% | +1.8% | −8.2% |
| 90 days | +16.4% | +5.3% | +11.1% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
The money chief of Encompass Health sold $107 of Encompass Health shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.